Kumar Singh Saikatendu

Senior Director

Kumar Singh Saikatendu picture

Kumar Singh Saikatendu

Takeda Pharmaceuticals

Senior Director

  • Ph.D Molecular Biophysics; Indian Institute of Science, Bangalore India 2001
  • Post Doc research: 2001-2004 Univ. Texas Southwestern Medical Center Dallas TX. USA
  • Sr. Research Associate 2004-2008 The Scripps Research Institute La Jolla, CA, USA
  • Takeda Pharmaceuticals 2008 – present. Currently serving as Head of Takeda’s Lipid nanoparticle platform in Drug Discovery Sciences team; Board of Directors of Structural Genomics Consortium; Project Co-Lead of IMI-CARE consortium – EU’s largest COVID research consortium.